Abstract
Background
This study sought to identify the factors associated with the occurrence of in-hospital
serious adverse events after elective endovascular aortic repair (EVAR) in older patients
within the Global Registry for Endovascular Aortic Treatment.
Methods
Consecutive patients ages ≥75 years who received GORE EXCLUDER AAA Endoprosthesis
(W.L. Gore & Associates, Inc, Flagstaff, AZ) for elective EVAR. Based on the age at
index elective EVAR, patients were categorized into 3 groups for subsequent analyses:
those ages 75 to 79, 80 to 84, and ≥85 years. The primary end points for this study
were the incidence of serious adverse events and all-cause mortality. In-hospital
complications were defined according to the International Organization for Standardization
14155 standard (https://www.iso.org/standard/71690.html) and considered serious adverse events if they led to any of the following: (1) a
life-threatening illness or injury, (2) a permanent impairment of a body structure
or a body function, (3) in-patient or prolonged hospitalization, or (4) medical or
surgical intervention to prevent life-threatening illness or injury or permanent impairment
to a body structure or a body function.
Results
Overall, 1,333 older patients (ages 75–79: n = 601; 80–84: n = 474; and ≥85: n = 258) underwent elective EVAR in the Global Registry for Endovascular Aortic Treatment
data set and were included in the present analysis. In total, 12 patients (0.9%) died
perioperatively, and 103 patients (7.7%) experienced ≥1 in-hospital serious adverse
event, with 18 patients (1.3%) experiencing >1 in-hospital complications. No significant
differences were seen between the age groups in the rates of in-hospital serious adverse
events (7.3% vs 8.2% vs 7.8%; P = .86). In logistic regression analysis, a history of chronic obstructive pulmonary
disease (odds ratio = 2.014; 95% confidence interval, 1.215–3.340; P = .006) and prior requirement for dialysis (odds ratio = 4.655; 95% confidence interval,
1.087–19.928; P = .038) resulted as predictors for occurrence of in-hospital serious adverse events.
In the whole cohort, the 5-year survival was 63% for patients who did not experience
any in-hospital serious adverse events compared with 51% for those who experienced
any complications (P = .003). Using multivariable Cox proportional hazards models, it was found that the
occurrence of in-hospital serious adverse events (hazard ratio = 6.2; 95% confidence
interval, 1.8–21.317; P = .003) and being underweight (hazard ratio = 7.0; 95% confidence interval, 1.371–35.783;
P = .019) were the only independent predictors of death in ≤30 days from the initial
intervention. Although age did not independently affect the risk for all-cause mortality
in ≤180 days after the initial intervention, increasing age was associated with a
higher risk for long-term death (ie, ≥181 days from index elective EVAR) in the multivariable
analysis (ages 75–79: hazard ratio = 0.379; 95% confidence interval, 0.281–0.512;
P < .001; and 80–84: hazard ratio = 0.562; 95% confidence interval, 0.419–0.754; P < .001).
Conclusion
After elective EVAR in older patients (ie, ≥75 years), the occurrence of in-hospital
serious adverse events appears to increase the risk of death, particularly in ≤180
days after the initial elective EVAR intervention, and might be related to patient
baseline characteristics, including history of pulmonary and renal disease.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology of aortic aneurysm repair in the United States from 2000 to 2010.J Vasc Surg. 2014; 59: 1512-1517
- Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: systematic review and meta-analysis.Eur J Vasc Endovasc Surg. 2011; 42: 571-576
- Outcomes of endovascular abdominal aortic aneurysm repair in octogenarians: meta-analysis and systematic review.Eur J Vasc Endovasc Surg. 2017; 54: 454-463
- Predictors of in-hospital adverse events after endovascular aortic aneurysm repair.J Vasc Surg. 2019; 70: 80-91
- Determinants of long-term survival after major surgery and the adverse effect of postoperative complications.Trans Meet Am Surg Assoc. 2005; 123: 32-48
- Editor’s choice – influence of proximal aortic neck diameter on durabillity of aneurysm sealing and overall survival in patients undergoing endovascular aneurysm repair: real world data from the Gore Global Registry for Endovascular Aortic Treatment (GREAT).Eur J Vasc Endovas. Surg. 2018; 56: 189-199
- Editor’s choice – European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms.Eur J Vasc Endovasc Surg. 2019; 57: 8-93
- Endovascular aneurysm repair in patients over 75 is associated with excellent 5-year survival, which suggests benefit from expanded screening into this cohort.J Vasc Surg. 2019; 69: 728-737
- Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.J Vasc Surg. 2010; 52: 539-548
- Ageing and the epidemiology of multimorbidity.Eur Resp J. 2014; 44: 1055-1068
- Long-term age-stratified survival following endovascular and open abdominal aortic aneurysm repair.J Vasc Surg. 2022; 76: 99-907
- Survival after uncomplicated EVAR in octogenarians is similar to the general population of octogenarians without an abdominal aortic aneurysm.Eur J Vasc Endovasc Surg. 2020; 59: 740-747
- Factors associated with in-hospital complications and long-term implications of these complications in elderly patients undergoing endovascular aneurysm repair.J Vasc Surg. 2020; 71: 470-480
- Functional status predicts major complications and death after endovascular repair of abdominal aortic aneurysms.J Vasc Surg. 2017; 66: 743-750
- Complication profile, failure to rescue, and mortality following elective endovascular aortic aneurysm repair.Am J Surg. 2017; 214: 307-311
- Predicting failure to rescue after abdominal aortic aneurysm repair in elderly patients.J Surg Res. 2017; 217: 265-270
- Interaction between frailty and sex on mortality after elective abdominal aortic aneurysm repair.J Vasc Surg. 2019; 70: 1831-1843
- Frailty factors and outcomes in vascular surgery patients. A systematic review and meta-analysis.Ann Surg. 2020; 272: 266-276
- Scoping review of frailty in vascular surgery.J Vasc Surg. 2019; 69: 198-1998
- Assessment of failure to rescue after abdominal aortic aneurysm repair using the National Surgical Quality Improvement Program procedure-targeted data set.J Vasc Surg. 2018; 68: 1335-1444
- Association between hospital volume and failure to rescue after open or endovascular repair of intact abdominal aortic aneurysms in the VASCUNET and International Consortium of Vascular Registries.Ann Surg. 2021; 1: e452-e459
- Center volume is associated with diminished failure to rescue and improved outcomes following elective open abdominal aortic aneurysm repair.J Vasc Surg. 2022; 76: 400-408.e2
- Long-term benefits of EVAR in the modern era: the importance of looking at stent-graft durability without forgetting the right pathophysiology.Eur J Vasc Endovasc Surg. 2020; 60: 956-957
- Long-term freedom from aneurysm-related mortality remains favorable after endovascular abdominal aortic aneurysms repair in a 15-year multicenter registry.J Vasc Surg. 2020; 71: 790-798
- Validation of a preoperative prediction model for mortality within 1 year after endovascular aortic aneurysm repair of intact aneurysms.J Vasc Surg. 2019; 70: 449-461
- A cost calculation of EVAR and FEVAR procedures at an European academic hospital.Ann Vasc Surg. 2019; 54: 205-214
- The UK EndoVascular Aneurysm Repair (EVAR) randomized controlled trials: long-term follow-up and cost-effectiveness analysis.Health Technol Assess. 2018; 22: 1-132
- A scoping review of the rationale and evidence for cost-eefectiveness analysis of fenestrated-branched endovascular repair for intact complex aortic aneurysms.J Vasc Surg. 2020; 72: 1772-1782
- Impact of proximal neck anatomy on short-term and mid-term outcomes after treatment of abdominal aortic aneurysms with new-generation low-profile endografts: results from the multicentric “ITAlian north-east registry of ENDOvascular aortic repair with the BOltOn Treo endograft (ITA-ENDOBOOT)”.Ann Vasc Surg. 2022; 80: 37-49
- Expert opinion on hostile neck definition in endovascular treatment of abdominal aortic aneurysms (a Delphi Consensus).Ann Vasc Surg. 2020; 62: 173-182
Article info
Publication history
Published online: December 14, 2022
Accepted:
November 13,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2022 Elsevier Inc. All rights reserved.
